Capsules containing aqueous fill compositions stabilized with derivatized cyclodextrin
View Patent ↗A capsule containing an aqueous fill composition that comprises water, a derivatized cyclodextrin, such as sulfoalkyl ether cyclodextrin (SAE-CD) or hydroxypropyl cyclodextrin (HPCD), optionally one or more active agents and optionally one or more excipients is stabilized from degradation, erosion, swelling or dissolution of its shell during storage. The derivatized cyclodextrin is present in an amount sufficient to reduce, eliminate or inhibit degradation, erosion, swelling and/or dissolution of the shell by water present in the fill composition. Alternatively, the derivatized cyclodextrin and another shell-stabilizing material together stabilize the shell from degradation, erosion, swelling and/or dissolution by water present in the fill composition. The derivatized cyclodextrin can reduce the water activity of the fill composition.
1. A capsule comprising:
a water soluble, erodible, degradable and/or swellable shell; and
an aqueous fill composition comprising one or more active agents, water in an amount of at least 10% to less than 50%, by weight, of the fill composition, and a water soluble cyclodextrin derivative in an amount of at least 50%, by weight, of the fill composition, wherein the capsule has a shelf-life of at least one week;
wherein the fill composition has a water activity of less than 0.95±0.01, and wherein the water soluble cyclodextrin derivative is a sulfoalkyl ether cyclodextrin of formula 1:
wherein: n is 4, 5 or 6; R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 and R 9 are each, independently, —O—or —O—(C 2 -C 6 alkylene)—SO 3 − , wherein at least one of R 1 , R 2 R 3 , R 4 , R 5 , R 6 , R 7 , R 8 and R 9 is independently —O—(C 2 -C 6 alkylene)—SO 3 − selected from the group consisting of: —O—(CH 2 ) m SO 3 − wherein m is 2 to 6, —OCH 2 CH 2 CH 2 SO 3 − , and —OCH 2 CH 2 CH 2 CH 2 SO 3 − ; and wherein S 1 ,S 2 ,S 3 ,S 4 , S 5 , S 6 , S 7 , S 8 , and S 9 are each, independently, a cation.
2. The capsule of claim 1 , wherein the aqueous fill composition is water miscible.
3. The capsule of claim 1 , wherein the active agent is present in a therapeutically effective amount.
4. The capsule of claim 1 , wherein the active agent is present in a sub-therapeutically effective amount.
5. The capsule of claim 1 , wherein the active agent is sparingly soluble, slightly soluble, very slightly soluble, practically insoluble or insoluble in water.
6. The capsule of claim 1 , wherein the active agent is more soluble in the aqueous fill composition than it is in water.
7. The capsule of claim 1 , wherein the water soluble cyclodextrin derivative solubilizes the active agent when it is released into an environment of use.
8. The capsule of claim 1 , wherein the active agent complexes with the cyclodextrin derivative to form an inclusion complex and/or a non-covalent ionic complex.
9. The capsule of claim 1 , wherein the active agent is soluble, freely soluble or very soluble in water.
10. The capsule of claim 1 , wherein the fill composition further comprises alcohol or other water miscible hydroxy moiety-containing material.
11. The capsule of claim 1 , wherein the cation is independently selected at each occurrence from the group consisting of: H + , an alkali metal cation, an alkaline earth metal cation, an ammonium cation, and an organic amine cation.
12. The capsule of claim 1 , wherein the capsule has a shelf life of at least 7 days.
13. The capsule of claim 12 , wherein the active agent is sparingly soluble, slightly soluble, very slightly soluble, practically insoluble or insoluble in water; and the cyclodextrin derivative solubilizes the active agent when it is released into an environment of use.
14. An aqueous fill composition in a water erodible, degradable, swellable and/or soluble shell, the fill composition comprising:
water in an amount of at least 10%, by weight, to less than 50%, by weight, of the fill composition,
a water soluble cyclodextrin derivative in an amount of at least 50%, by weight, of the fill composition,
one or more active agents, and
optionally one or more excipients,
wherein the water soluble cyclodextrin derivative is present in an amount sufficient to reduce erosion, degradation, swelling or dissolution of the shell caused by the water in the fill composition, were the water soluble cyclodextrin derivative absent, for a period of at least one week, in the absence of another shell-stabilizing material;
wherein the water activity of the fill composition is less than about 0.95±0.01; and
wherein the water soluble cyclodextrin derivative is a sulfoalkyl ether cyclodextrin of formula 1:
wherein: n is 4, 5 or 6; R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 and R 9 are each, independently, —O—or —O—(C 2 -C 6 alkylene)—SO 3 − , wherein at least one of R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 and R 9 is independently —O—(C 2 -C 6 alkylene)—SO 3 − selected from the group consisting of: —O—(CH 2 ) m SO 3 − wherein m is 2 to 6, —OCH 2 CH 2 CH 2 SO 3 − , and —OCH 2 CH 2 CH 2 CH 2 SO 3 − ; and wherein S 1 , S 2 , S 3 , S 4 , S 5 , S 6 , S 7 , S 8 and S 9 are each, independently, a cation.
15. The capsule of claim 14 , wherein the water activity of the aqueous fill composition is less than about 0.9.
16. The capsule of claim 14 , wherein the water soluble cyclodextrin is present in an amount of ≧55%, by weight, of the fill composition.
17. The capsule of claim 14 , wherein the water soluble cyclodextrin is present in an amount of ≧60%, by weight, of the fill composition.
18. The capsule of claim 14 , wherein the water activity of the aqueous fill composition is less than about 0.925.
19. The fill composition of claim 14 , wherein the cation is independently selected at each occurrence from the group consisting of H + , an alkali metal cation, an alkaline earth metal cation, an ammonium cation, and an organic amine cation.